Class information for:
Level 1: KANGEN KARYU//DAN GUA FANG//ALDOSE REDUCTASE INHIBITOR ONO 2235

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
30687 165 33.5 63%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
334 3       PHYSICAL ACTIVITY//EXERCISE//JOURNAL OF PHYSICAL ACTIVITY & HEALTH 37689
2464 2             STREPTOZOTOCIN//KANGEN KARYU//HYPERCYTOLIPIDEMIA 4004
30687 1                   KANGEN KARYU//DAN GUA FANG//ALDOSE REDUCTASE INHIBITOR ONO 2235 165

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 KANGEN KARYU authKW 2405827 8% 100% 13
2 DAN GUA FANG authKW 246750 1% 67% 2
3 ALDOSE REDUCTASE INHIBITOR ONO 2235 authKW 185064 1% 100% 1
4 CONCURRENT TREATMENT OF PHLEGM AND BLOOD STASIS authKW 185064 1% 100% 1
5 CULTURED RETINAL CAPILLARY ENDOTHELIAL CELLS authKW 185064 1% 100% 1
6 DAN GUA PRESCRIPTION authKW 185064 1% 100% 1
7 DEV ADV THER Y MED PROD address 185064 1% 100% 1
8 GLUCOSE CYTOTOXICITY authKW 185064 1% 100% 1
9 HARMLESS HYPERGLYCEMIA authKW 185064 1% 100% 1
10 IODINE 123 TYR A14 INSULIN authKW 185064 1% 100% 1

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Endocrinology & Metabolism 1167 33% 0% 54
2 Integrative & Complementary Medicine 480 7% 0% 11
3 Pharmacology & Pharmacy 81 15% 0% 25
4 Physiology 68 8% 0% 13
5 Ophthalmology 53 5% 0% 9
6 Medicine, Research & Experimental 45 7% 0% 12
7 Peripheral Vascular Diseases 43 5% 0% 9
8 Cell Biology 32 9% 0% 15
9 Biophysics 24 5% 0% 9
10 CYTOLOGY & HISTOLOGY 23 1% 0% 1

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 DEV ADV THER Y MED PROD 185064 1% 100% 1
2 URA CNRS 1813 185064 1% 100% 1
3 KLIN CHEM ORDIAGNOST 92531 1% 50% 1
4 METAB BRANCH ENDOCRINE SECT 92531 1% 50% 1
5 ANATOMICUM 61687 1% 33% 1
6 BIOCHEM PHARMACOL BIOCHEM CELL REGULAT SECT 61687 1% 33% 1
7 NIHONBASHI 61687 1% 33% 1
8 ORG PROMOT REG ABORAT 52872 1% 14% 2
9 JDRF COMPLICAT DIABET 46264 1% 25% 1
10 PHARMAZEUT BIOL MIKROBIOL 46264 1% 25% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 CHINESE JOURNAL OF INTEGRATIVE MEDICINE 2875 2% 0% 4
2 DIABETES 2213 7% 0% 12
3 IUGOSLAVICA PHYSIOLOGICA ET PHARMACOLOGICA ACTA 1516 1% 0% 2
4 NEUROCHEMICAL PATHOLOGY 1422 1% 1% 1
5 DIABETES RESEARCH CLINICAL AND EXPERIMENTAL 1288 1% 0% 2
6 DIABETES NUTRITION & METABOLISM 1160 1% 0% 2
7 JOURNAL OF PHARMACY AND PHARMACOLOGY 1126 4% 0% 7
8 MICROVASCULAR RESEARCH 1112 2% 0% 4
9 METABOLISM-CLINICAL AND EXPERIMENTAL 1017 4% 0% 7
10 ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH 561 1% 0% 1

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 KANGEN KARYU 2405827 8% 100% 13 Search KANGEN+KARYU Search KANGEN+KARYU
2 DAN GUA FANG 246750 1% 67% 2 Search DAN+GUA+FANG Search DAN+GUA+FANG
3 ALDOSE REDUCTASE INHIBITOR ONO 2235 185064 1% 100% 1 Search ALDOSE+REDUCTASE+INHIBITOR+ONO+2235 Search ALDOSE+REDUCTASE+INHIBITOR+ONO+2235
4 CONCURRENT TREATMENT OF PHLEGM AND BLOOD STASIS 185064 1% 100% 1 Search CONCURRENT+TREATMENT+OF+PHLEGM+AND+BLOOD+STASIS Search CONCURRENT+TREATMENT+OF+PHLEGM+AND+BLOOD+STASIS
5 CULTURED RETINAL CAPILLARY ENDOTHELIAL CELLS 185064 1% 100% 1 Search CULTURED+RETINAL+CAPILLARY+ENDOTHELIAL+CELLS Search CULTURED+RETINAL+CAPILLARY+ENDOTHELIAL+CELLS
6 DAN GUA PRESCRIPTION 185064 1% 100% 1 Search DAN+GUA+PRESCRIPTION Search DAN+GUA+PRESCRIPTION
7 GLUCOSE CYTOTOXICITY 185064 1% 100% 1 Search GLUCOSE+CYTOTOXICITY Search GLUCOSE+CYTOTOXICITY
8 HARMLESS HYPERGLYCEMIA 185064 1% 100% 1 Search HARMLESS+HYPERGLYCEMIA Search HARMLESS+HYPERGLYCEMIA
9 IODINE 123 TYR A14 INSULIN 185064 1% 100% 1 Search IODINE+123+TYR+A14+INSULIN Search IODINE+123+TYR+A14+INSULIN
10 LABELLED INSULIN 185064 1% 100% 1 Search LABELLED+INSULIN Search LABELLED+INSULIN

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 BAR, RS , BOES, M , DAKE, BL , BOOTH, BA , HENLEY, SA , SANDRA, A , (1988) INSULIN, INSULIN-LIKE GROWTH-FACTORS, AND VASCULAR ENDOTHELIUM.AMERICAN JOURNAL OF MEDICINE. VOL. 85. ISSUE 5A. P. 59-70 22 61% 99
2 BAR, RS , BOES, M , SANDRA, A , (1988) VASCULAR TRANSPORT OF INSULIN TO RAT CARDIAC-MUSCLE - CENTRAL ROLE OF THE CAPILLARY ENDOTHELIUM.JOURNAL OF CLINICAL INVESTIGATION. VOL. 81. ISSUE 4. P. 1225-1233 9 69% 38
3 MOON, HR , PARK, CH , KIM, DH , PARK, MH , KIM, MK , KIM, ND , KIM, CM , TANAKA, T , YOKOZAWA, T , CHUNG, HY , (2014) CHINESE PRESCRIPTION KANGEN-KARYU AND SALVIAE MILTIORRHIZAE RADIX IMPROVE AGE-RELATED OXIDATIVE STRESS AND INFLAMMATORY RESPONSE THROUGH THE PI3K/AKT OR MAPK PATHWAYS.AMERICAN JOURNAL OF CHINESE MEDICINE. VOL. 42. ISSUE 4. P. 987 -1005 11 23% 7
4 BAR, RS , BOES, M , YOREK, M , (1986) PROCESSING OF INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II BY CAPILLARY AND LARGE VESSEL ENDOTHELIAL-CELLS.ENDOCRINOLOGY. VOL. 118. ISSUE 3. P. 1072-1080 10 63% 37
5 HENG, XP , CHEN, KJ , HONG, ZF , HE, WD , CHU, KD , LIN, JM , ZHENG, HX , YANG, LQ , HUANG, SP , LAN, YL , ET AL (2013) TOXICITY FEATURES OF HIGH GLUCOSE ON ENDOTHELIAL CELL CYCLE AND PROTECTION BY DAN GUA-FANG (A(1)C"EAE-(1)) IN ECV-304 IN HIGH GLUCOSE MEDIUM.CHINESE JOURNAL OF INTEGRATIVE MEDICINE. VOL. 19. ISSUE 8. P. 596-602 6 40% 1
6 BAR, RS , SIDDLE, K , DOLASH, S , BOES, M , DAKE, B , (1988) ACTIONS OF INSULIN AND INSULINLIKE GROWTH FACTOR-I AND FACTOR-II IN CULTURED MICROVESSEL ENDOTHELIAL-CELLS FROM BOVINE ADIPOSE-TISSUE.METABOLISM-CLINICAL AND EXPERIMENTAL. VOL. 37. ISSUE 8. P. 714-720 10 53% 31
7 BAR, RS , BOES, M , SANDRA, A , (1988) IGF RECEPTORS IN MYOCARDIAL CAPILLARY ENDOTHELIUM - POTENTIAL REGULATION OF IGF-I TRANSPORT TO CARDIAC-MUSCLE.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 152. ISSUE 1. P. 93-98 8 67% 12
8 BAR, RS , DOLASH, S , DAKE, BL , BOES, M , (1986) CULTURED CAPILLARY ENDOTHELIAL-CELLS FROM BOVINE ADIPOSE-TISSUE - A MODEL FOR INSULIN BINDING AND ACTION IN MICROVASCULAR ENDOTHELIUM.METABOLISM-CLINICAL AND EXPERIMENTAL. VOL. 35. ISSUE 4. P. 317-322 8 73% 22
9 CHERNICK, SS , GARDINER, RJ , SCOW, RO , (1987) RESTRICTED PASSAGE OF INSULIN ACROSS CAPILLARY ENDOTHELIUM IN PERFUSED RAT ADIPOSE-TISSUE.AMERICAN JOURNAL OF PHYSIOLOGY. VOL. 253. ISSUE 5. P. E475-E480 7 78% 19
10 VINTERS, HV , BERLINER, JA , (1987) THE BLOOD-VESSEL WALL AS AN INSULIN TARGET TISSUE.DIABETES & METABOLISM. VOL. 13. ISSUE 3BIS. P. 294-300 12 38% 32

Classes with closest relation at Level 1



Rank Class id link
1 24093 CLIN MEDDISCIPLINA MED INTERNA//BRAIN INSULIN//BALANCO HIDRO SALINO NUCL MED CIRURGIA EXPT
2 10907 NUTRITIVE FLOW//NON NUTRITIVE FLOW//INSULIN TRANSPORT
3 18494 RUBOXISTAURIN//LY333531//PKC BETA II INHIBITORS
4 12761 ANGIOTROPIN CURNP RIBOKINE//PATHOL MED S113//AGE RELATED DECREASE IN PGI2 PRODUCTION
5 35142 THRP//AGING BLOOD BRAIN BARRIER//ANTIOXIDANTS HYPERGLYCEMIA
6 30937 INNER BLOOD RETINAL BARRIER//PROTON COUPLED ORGANIC CATION ANTIPORTER//RETINAL CAPILLARY ENDOTHELIAL CELLS
7 35237 2 NBDG//2 NBDLG//FLUORESCENT GLUCOSE
8 9930 PHYSIOL MORPHOL//RAT AORTAE//DIABETES
9 9990 INSULIN DEGRADING ENZYME//INSULIN DEGRADATION//IDE
10 11624 JOHN COOK RENAL UNIT//PLATELET HYPERSENSITIVITY//5 4 CHLOROBENZYL 2 4 DIMETHYLBENZAMIL

Go to start page